What you say is perfectly valid for a trader with a 90-day horizon. It does not make the slightest sense for investors who have held over a considerable period of time. It makes no sense to continue buying as the share price falls, increasing exposure and risk, often with a substantial proportion of their wealth exposed to the company's future. Many holders have been holding, waiting for the process of commercialisation to get traction and for some upside to appear, and planning how and when to invest in the upward trajectory.
Many holders here have waited patiently against that future based entirely on the prognostications of Tony Keating and Brian Leedman.
So I think it quite ironic and more than a little hypocritical of Mr Leedman, who has encouraged and inflated the expectations of shareholders, to now be "exasperated" that those same shareholders are now rather disappointed and bitter.
It looks to me as if Messers Leedman and Keating are finally confessing that they have done their best and are not capable of delivering more. It's time for them to go and we can try to find people who are up to the job.
- Forums
- NZX - By Stock
- RAP
- What's a fair offer from Pfizer?
What's a fair offer from Pfizer?, page-27
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online